Public market insider buying at Profound Medical (PRN)

Public market insider buying at Profound Medical (T:PRN)

Updated Monday May 16, 2022 04:24 AM EDT
Arun Menawat, CEO and Director, acquired 30,516 Common Shares on a direct ownership basis at a price of $6.655USD on May 12th, 2022. This represents a $264,793 investment into the company's shares and an account share holdings change of 8.8%.

Ken Knudson, a Senior Officer, acquired 8,000 Common Shares on a direct ownership basis at a price of $7.066USD on May 12th, 2022. This represents a $73,704 investment into the company's shares and an account share holdings change of greater than 100%.

Profound Medical is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.

Headlines: May 16, 2022

PRN Insider Holdings Chart

Issuer details as of May 16, 2022 4:24 ET

Latest Price
9.01
1 Day Change
5.63%
52 Week High
23.67
52 Week Low
8
QMV ($Mils)
187,223,448


Top